✦ LIBER ✦

Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma

✍ Scribed by Martin Kaiser; Britta Lamottke; Maren Mieth; Michael R. Jensen; Cornelia Quadt; Carlos Garcia-Echeverria; Peter Atadja; Ulrike Heider; Ivana Von Metzler; Seval Türkmen; Orhan Sezer

Book ID: 114794728
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 278 KB
Volume: 84
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2009.01403.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B381 Synergistic Action of Heat-Shock Pr

B381 Synergistic Action of Heat-Shock Protein—90 Inhibitor NVP-AUY922 with Histone Deacetylase Inhibition

✍ Kaiser, M; Lamottke, B; Jensen, MR; Quadt, C; Garcia-Echeverria, C; Mieth, M; He 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 97 KB

Signalling profile and antitumour activi

Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma

✍ Stühmer, T; Zöllinger, A; Siegmund, D; Chatterjee, M; Grella, E; Knop, S; Kortüm 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 360 KB

The novel, orally bioavailable HSP90 inh

The novel, orally bioavailable HSP90 inhibitor NVP-HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases

✍ Britta Lamottke; Martin Kaiser; Maren Mieth; Ulrike Heider; Zhenhai Gao; Zariana 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB